Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 5, 2007, Pages 1010-1012

  Cattoir, Vincent ^a   Merabet, Lilia ^a   Legrand, Patrick ^a   Soussy, Claude James ^a   Leclercq, Roland ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Macrolide resistance; Pneumococcus; Riboprotein; RplV

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMPICILLIN; AZITHROMYCIN; BETA LACTAM DERIVATIVE; CEFOTAXIME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENOMIC DNA; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; MACROLIDE; MIKAMYCIN B; PENICILLIN G; PRISTINAMYCIN; RIBOSOME PROTEIN; RIBOSOME RNA; RIFAMPICIN; SPIRAMYCIN; STREPTOGRAMIN DERIVATIVE; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BLOOD CULTURE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENE INSERTION; HUMAN; LOBAR PNEUMONIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PNEUMONIA, PNEUMOCOCCAL; PRISTINAMYCIN; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; SEQUENCE ALIGNMENT; STREPTOCOCCUS PNEUMONIAE; STREPTOGRAMINS;

EID: 34447579935     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm041     Document Type: Article

References (12)

1. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
2. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimictob Agents Chemother 2002; 46: 2727-34.
3. Bruinsma N, Kristinsson KG, Bronzwaer S et al. Trends of penicillin and erythromycin resistance among invasive Streprococcus pneumoniae in Europe. J Antimicrob Chemother 2004; 54: 1045-50.
4. Pankuch GA, Visalli MA, Jacobs MR et al. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob Agents Chemother 1998; 42: 624-30.
5. Comité de l'Antibiogramme de la Sociét ̧Française de Microbiologie. Communiqué 2006. www.sfm.asso.fr (15 November 2006, date last accessed).
6. Canu A, Malbruny B, Coquemont M et al. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002; 46: 125-31.
7. Burucoa C, Pasdeloup T, Chapon C et al. Failure of pristinamycin treatment in a case of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 1995; 14: 341-2.
8. Brevet-Coupe F, Guerin B, Watine J. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus. Scand J Infect Dis 1998; 30: 419-20.
9. Depardieu F, Courvalin P. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 319-23.
10. Weber P. Streptococcus pneumoniae: Lack of emergence of pristinamycin resistance. Pathol Biol (Paris) 2001; 49: 840-5.
11. Musher DM, Dowell ME, Shortridge VD et al. Emergence of macrolide resistance during treatment of preumococcal pneumonia. N Engl J Med 2002; 346: 630-1.
12. BK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 2005; 121: 257-70.